The expression and clinical significance of PI3K, pAkt and VEGF in colon cancer
- Authors:
- Yinxu Zhang
- Xiaomei Liu
- Junhua Zhang
- Leiyu Li
- Chunying Liu
View Affiliations
Affiliations: Department of Pathology, Liaoning University of Traditional Chinese Medicine, Shenyang 110032, P.R. China, Department of Surgery, The First Affiliated Hospital of Liaoning Medical University, Jinzhou, Liaoning 121001, P.R. China
- Published online on: July 25, 2012 https://doi.org/10.3892/ol.2012.822
-
Pages:
763-766
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Background PI3K/Akt signaling has been shown to be activated in a variety of cancers. However, the correlation between Akt activation and VEGF expression is unclear in colon cancer tissues. This study aimed to investigate the expression and predictive value of phosphorylated Akt (pAkt) and VEGF in colon cancer tissues. The expression of PI3K, pAkt and VEGF was detected by immunohistochemical staining in 60 samples of colon cancer tissues and their corresponding adjacent normal colon tissues. In addition, the correlations between the expression levels of the 3 proteins and the clinicopathological parameters of the colon cancer cases were analyzed. The positive rates of PI3K, pAkt and VEGF expression were 71.7% (43/60), 68.3% (41/60) and 61.7% (37/60) in colon cancer, respectively, which were significantly higher than in adjacent normal colon tissues (P<0.001). Correlation analyses showed that PI3K expression was not significantly associated with the gender or age of the patients, tumor size or differentiation (P>0.05), but was closely associated with serous coat infiltration and lymphatic metastasis of colon cancer (P<0.05). Neither pAkt nor VEGF expression were significantly associated with the gender or age of the patients, or tumor differentiation (P>0.05), but were closely associated with tumor size, serous coat infiltration and lymphatic metastasis of colon cancer (P<0.05). In addition, the expression levels of Pl3K and pAkt were positively correlated with that of VEGF in colon cancer tissues (P<0.05). Our data show a positive correlation between PI3K/Akt activation and VEGF expression in colon cancer tissues and indicate that pAkt is an independent prognostic marker for colon cancer patients.
View References
|
1.
|
L YangDM ParkinL LiTime trends in cancer
mortality in China: 1987–1999Int J Cancer1067717832003
|
|
2.
|
V DuronioThe life of a cell: apoptosis
regulation by the PI3K/PKB pathwayBiochem
J415333344200810.1042/BJ2008105618842113
|
|
3.
|
A HlobilkovaJ EhrmannE SedlakovaV KrejciP
KnizetovaCould changes in the regulation of the PI3K/PKB/Akt
signaling pathway and cell cycle be involved in astrocytic tumor
pathogenesis and progression?Neoplasma54334341200717822324
|
|
4.
|
C HuangR HuangW ChangT JiangK HuangThe
expression and clinical significance of pSTAT3, VEGF and VEGF-C in
pancreatic
adenocarcinomaNeoplasma595261201210.4149/neo_2012_00722082308
|
|
5.
|
M KozlowskiW NaumnikJ NiklinskiR MilewskiP
DziegielewskiJ LaudanskiVascular endothelial growth factor C and D
expression correlates with lymph node metastasis and poor prognosis
in patients with resected esophageal
cancerNeoplasma58311319201110.4149/neo_2011_04_31121520987
|
|
6.
|
F WangP ZhangC ShiImmunohistochemical
detection of HSP27 and hnRNP K as prognostic and predictive
biomarkers for colorectal cancerMed OncolAug232011(Epub ahead of
print)
|
|
7.
|
QL LiangZY LiGQ ChenPrognostic value of
serum soluble Fas in patients with locally advanced unresectable
rectal cancer receiving concurrent chemoradiotherapyJ Zhejiang Univ
Sci B11912917201010.1631/jzus.B1000277
|
|
8.
|
QL LiangBR WangGH LiDcR3 and survivin are
highly expressed in colorectal carcinoma and closely correlated to
its clinicopathologic parametersJ Zhejiang Univ Sci
B10675682200910.1631/jzus.B0920077
|
|
9.
|
S HasselblomU HanssonM OlssonL TorenA
BergstromHigh immunohistochemical expression of p-AKT predicts
inferior survival in patients with diffuse large B-cell lymphoma
treated with immunochemotherapyBr J
Haematol149560568201010.1111/j.1365-2141.2010.08123.x20201946
|
|
10.
|
A YoshiokaH MiyataY DokiT YasudaM
YamasakiThe activation of Akt during preoperative chemotherapy for
esophageal cancer correlates with poor prognosisOncol
Rep1910991107200818425364
|
|
11.
|
A ValkovTK KilvaerSW SorbyeT DonnemE
SmelandThe prognostic impact of Akt isoforms, PI3K and PTEN related
to female steroid hormone receptors in soft tissue sarcomasJ Transl
Med9200201110.1186/1479-5876-9-20022107784
|
|
12.
|
AK OlssonA DimbergJ KreugerL
Claesson-WelshVEGF receptor signalling - in control of vascular
functionNat Rev Mol Cell Biol7359371200610.1038/nrm191116633338
|
|
13.
|
MT DellingerRA BrekkenPhosphorylation of
Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation
and migration of lymphatic endotheliumPLoS
One6e28947201110.1371/journal.pone.002894722174934
|
